Thor Medical Competitors and Similar CompaniesClear all
Thor Medical's competitors and similar companies include Brii Biosciences, Molecular Partners, Abliva and ViewPoint Therapeutics.
 Thor Medical Thor Medical (formerly known as Nordic Nanovector) is a biopharmaceutical company that focuses on the development and commercialisation of novel targeted therapeutics in haematology and oncology. |  Brii Biosciences Brii Biosciences researches and develops medicines for the treatment of chronic illnesses with significant burdens, including infectious diseases, liver and lung diseases, and other illnesses. |  Molecular Partners Molecular Partners is a company that develops biopharmaceutical products for serious diseases. |  Abliva Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease. |  ViewPoint Therapeutics ViewPoint Therapeutics is a biotechnology company which develops treatments for diseases of protein misfolding, including cataracts. | |
Founding Date | Founding Date 2009 | Founding Date 2018 | Founding Date 2004 | Founding Date 2000 | Founding Date 2014 |
Type | Type Public | Type Private | Type Public | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations Oslo, NO HQ Zug, CH Shrewsbury, GB | Locations CN HQ Beijing, CN Durham, US San Francisco, US San Mateo, US | Locations Zürich-Schlieren, CH HQ Cambridge, US Concord, US | Locations Lund, SE HQ | Locations San Mateo, US HQ San Francisco, US |
Employees | Employees 3716% decrease | Employees 8510% decrease | Employees 158 | Employees 950% increase | Employees 1 |
Financial | |||||
Revenue (est.) | Revenue (est.) kr439k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit kr4.3m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit kr497k (FY, 2024) | Gross profit N/A |
Net income | Net income (kr58m) (FY, 2025) | Net income N/A | Net income (CHF61.7m) (FY, 2025) | Net income (kr90m) (FY, 2024) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 155m (about 5 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 35m (about 8 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 415m | Total funding raised N/A | Total funding raised $ 10.8m | Total funding raised $ 39m |
For sources of this data, please see the company profile
View Company Profiles
Brii Biosciences
HQ
CN
Employees
85↓ 10% decrease
Brii Biosciences researches and develops medicines for the treatment of chronic illnesses with significant burdens, including infectious diseases, liver and lung diseases, and other illnesses.
View companyMolecular Partners
HQ
Zürich-Schlieren, CH
Employees
158
Molecular Partners is a company that develops biopharmaceutical products for serious diseases.
View companyAbliva
HQ
Lund, SE
Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease.
View companyViewPoint Therapeutics
HQ
San Mateo, US
Employees
1
ViewPoint Therapeutics is a biotechnology company which develops treatments for diseases of protein misfolding, including cataracts.
View company